סטיוורגה
bayer israel ltd - regorafenib - טבליות מצופות פילם - regorafenib 40 mg - regorafenib - regorafenib - stivarga is indicated for the treatment of patients with metastatic colorectal cancer (crc) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf therapy, and if kras wild-type, an anti-egfr therapy.for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumors (gist) who have been previously treated with imatinib mesylate and sunitinib malate
ז'בלור
perrigo israel agencies ltd - vinflunine ditartrate - תרכיז להכנת תמיסה לאינפוזיה - vinflunine ditartrate 25 mg/ml - vinflunine - vinflunine - javlor is indicated in monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinium-containing regimen. efficacy and safety of vinflunine have not been studied in patients with performance status ?2.
קייליקס
j-c health care ltd - doxorubicin hydrochloride - liposome for infusion - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin - doxorubicin - first or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease the treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatmnt. as monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. in combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.
יירבוי 5 מגמל
bristol, myers squibb (israel) limited, israel - ipilimumab - תרכיז להכנת תמיסה לאינפוזיה - ipilimumab 5 mg/ml - ipilimumab - ipilimumab - yervoy (ipilimumab) is indicated for the treatment of unresectable or metastatic melanoma.
ארביטוקס 5 מגמל
merck serono ltd - cetuximab - תמיסה לאינפוזיה - cetuximab 5 mg/ml - cetuximab - cetuximab - erbitux® is indicated for the treatment of patients with epidermal growth factor receptor (egfr) - expressing, kras wild-type metastatic colorectal cancer• in combination with irinotecan-based chemotherapy• in first-line in combination with folfox• as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecanerbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (scchn)• in combination with radiation therapy for locally advanced disease• in combination with platinum-based chemotherapy for recurrent and/or metastatic disease• as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease
אופדיבו
bristol, myers squibb (israel) limited, israel - nivolumab - תרכיז להכנת תמיסה לאינפוזיה - nivolumab 10 mg/ml - nivolumab
לוריאל פרופשיונל משחת הבהרה בפעולה מהירה
אינטרביוטי קוסמטיקס ישראל בעמ - הבהרת השיער
לוריאל פרופשונל אינפיניום לומייר גמיש דרגת חוזק 1
אינטרביוטי קוסמטיקס ישראל בעמ - עיצוב השיער
לוריאל פרופשונל אינפיניום לומייר ספריי מקצועי גימור רגיל דרגת חוזק 2
אינטרביוטי קוסמטיקס ישראל בעמ - עיצוב השיער
לוריאל פרופשונל אינפיניום לומייר ספריי מקצועי גימור חזק דרגת חוזק 3
אינטרביוטי קוסמטיקס ישראל בעמ - עיצוב השיער